SK287819B6 - Dry powder pharmaceutical composition for oral administration - Google Patents
Dry powder pharmaceutical composition for oral administration Download PDFInfo
- Publication number
- SK287819B6 SK287819B6 SK76-2003A SK762003A SK287819B6 SK 287819 B6 SK287819 B6 SK 287819B6 SK 762003 A SK762003 A SK 762003A SK 287819 B6 SK287819 B6 SK 287819B6
- Authority
- SK
- Slovakia
- Prior art keywords
- pharmaceutical composition
- dry powder
- racecadotril
- powder pharmaceutical
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00401799 | 2000-06-23 | ||
| PCT/EP2001/007086 WO2001097801A2 (en) | 2000-06-23 | 2001-06-22 | Dry powder formulation comprising racecadotril |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK762003A3 SK762003A3 (en) | 2003-07-01 |
| SK287819B6 true SK287819B6 (sk) | 2011-11-04 |
Family
ID=8173739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK76-2003A SK287819B6 (sk) | 2000-06-23 | 2001-06-22 | Dry powder pharmaceutical composition for oral administration |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6919093B2 (da) |
| EP (1) | EP1294372B1 (da) |
| CN (2) | CN102151247A (da) |
| AT (1) | ATE301999T1 (da) |
| AU (1) | AU2001289606A1 (da) |
| BG (1) | BG66212B1 (da) |
| CA (1) | CA2415957C (da) |
| CZ (1) | CZ299591B6 (da) |
| DE (1) | DE60112756T2 (da) |
| DK (1) | DK1294372T3 (da) |
| ES (1) | ES2247163T3 (da) |
| SK (1) | SK287819B6 (da) |
| WO (1) | WO2001097801A2 (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2900823B1 (fr) | 2006-05-15 | 2009-02-13 | Bioprojet Soc Civ Ile | Nouvelle forme d'administration du racecadotril. |
| CN101103960B (zh) * | 2006-07-14 | 2010-12-08 | 海南盛科生命科学研究院 | 一种含有消旋卡多曲的干混悬剂及其制备方法 |
| EP2462922A1 (en) | 2010-12-10 | 2012-06-13 | Bioprojet | New form of administration of enkephalinase inhibitor |
| CN102166197B (zh) * | 2011-04-25 | 2012-09-05 | 四川百利药业有限责任公司 | 消旋卡多曲颗粒及其生产工艺 |
| EP2768537B1 (en) * | 2011-10-18 | 2019-02-20 | Purdue Pharma LP | Acrylic polymer formulations |
| RU2632441C2 (ru) | 2012-06-28 | 2017-10-04 | МакНЕЙЛ-ППС, ИНК. | Липидные композиции рацекадотрила |
| US9114171B2 (en) | 2012-06-28 | 2015-08-25 | Mcneil-Ppc, Inc. | Racecadotril liquid compositions |
| PT2866802T (pt) | 2012-06-28 | 2016-09-05 | Johnson & Johnson Consumer Inc | Composições líquidas racecadotril |
| US9801819B2 (en) | 2012-06-28 | 2017-10-31 | Johnson & Johnson Consumer Inc. | Racecadotril compositions |
| TR201801726T4 (tr) * | 2012-12-26 | 2018-03-21 | Ilko Ilac Sanayi Veticaret A S | Rasekadotri̇l ve farmasöti̇k bi̇leşi̇mleri̇. |
| EP2918268A1 (en) | 2014-03-10 | 2015-09-16 | Galenicum Health S.L. | Pharmaceutical compositions comprising an active agent |
| ES2555484T1 (es) | 2014-05-26 | 2016-01-04 | Galenicum Health S.L. | Composiciones farmacéuticas que contienen un agente activo |
| MA40859A (fr) | 2014-10-29 | 2017-09-05 | Johnson & Johnson Consumer Inc | Particules de cadotril |
| EP3558272A1 (en) | 2016-12-23 | 2019-10-30 | Hermes Arzneimittel GmbH | Oral pharmaceutical composition with improved taste-masking properties |
| WO2018163195A1 (en) | 2017-03-06 | 2018-09-13 | Athena Drug Delivery Solutions Pvt Ltd. | A pharmaceutical composition comprising racecadotril and process for preparing the same |
| CN109589310A (zh) * | 2017-10-01 | 2019-04-09 | 北京万全德众医药生物技术有限公司 | 消旋卡多曲干混悬剂及其制备方法 |
| GB2586201B (en) * | 2019-05-14 | 2023-05-24 | Orbit Pharmaceuticals | A stable powder formulation of racecadotril |
| EP4056171A1 (en) | 2021-03-12 | 2022-09-14 | Athena Pharmaceutiques SAS | Taste masked racecadotril tablet composition and process for preparation thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2480747A1 (fr) * | 1980-04-17 | 1981-10-23 | Roques Bernard | Derives d'acides amines et leur application therapeutique |
| ZA919510B (en) * | 1990-12-05 | 1992-10-28 | Smithkline Beecham Corp | Pharmaceutical compositions |
| GR1002332B (el) * | 1992-05-21 | 1996-05-16 | Mcneil-Ppc Inc. | Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη. |
| US5914132A (en) * | 1993-02-26 | 1999-06-22 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| EP0914822A4 (en) * | 1996-03-14 | 2002-08-07 | Bayer Ag | PREPARATION OF ECADOTRIL WITH FAST MICRODISPERSION AND RELEASE |
| US6649186B1 (en) * | 1996-09-20 | 2003-11-18 | Ethypharm | Effervescent granules and methods for their preparation |
| US6270804B1 (en) * | 1998-04-03 | 2001-08-07 | Biovail Technologies Ltd. | Sachet formulations |
| GB0015490D0 (en) * | 2000-06-23 | 2000-08-16 | Smithkline Beecham Lab | Novel formulations |
-
2001
- 2001-06-22 CN CN2011100456773A patent/CN102151247A/zh active Pending
- 2001-06-22 ES ES01969310T patent/ES2247163T3/es not_active Expired - Lifetime
- 2001-06-22 CA CA2415957A patent/CA2415957C/en not_active Expired - Lifetime
- 2001-06-22 SK SK76-2003A patent/SK287819B6/sk not_active IP Right Cessation
- 2001-06-22 DK DK01969310T patent/DK1294372T3/da active
- 2001-06-22 CN CNA018131867A patent/CN1635884A/zh active Pending
- 2001-06-22 AU AU2001289606A patent/AU2001289606A1/en not_active Abandoned
- 2001-06-22 EP EP01969310A patent/EP1294372B1/en not_active Expired - Lifetime
- 2001-06-22 AT AT01969310T patent/ATE301999T1/de active
- 2001-06-22 DE DE60112756T patent/DE60112756T2/de not_active Expired - Lifetime
- 2001-06-22 WO PCT/EP2001/007086 patent/WO2001097801A2/en active IP Right Grant
- 2001-06-22 CZ CZ20030185A patent/CZ299591B6/cs not_active IP Right Cessation
-
2003
- 2003-01-13 US US10/347,332 patent/US6919093B2/en not_active Expired - Lifetime
- 2003-01-20 BG BG107481A patent/BG66212B1/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1635884A (zh) | 2005-07-06 |
| DE60112756T2 (de) | 2006-06-08 |
| CZ299591B6 (cs) | 2008-09-10 |
| DE60112756D1 (de) | 2005-09-22 |
| BG66212B1 (bg) | 2012-05-31 |
| WO2001097801A3 (en) | 2002-09-12 |
| BG107481A (bg) | 2003-09-30 |
| CZ2003185A3 (cs) | 2003-05-14 |
| CA2415957C (en) | 2010-08-10 |
| ES2247163T3 (es) | 2006-03-01 |
| CA2415957A1 (en) | 2001-12-27 |
| WO2001097801A2 (en) | 2001-12-27 |
| ATE301999T1 (de) | 2005-09-15 |
| EP1294372A2 (en) | 2003-03-26 |
| DK1294372T3 (da) | 2005-09-19 |
| AU2001289606A1 (en) | 2002-01-02 |
| US20030166718A1 (en) | 2003-09-04 |
| EP1294372B1 (en) | 2005-08-17 |
| US6919093B2 (en) | 2005-07-19 |
| CN102151247A (zh) | 2011-08-17 |
| SK762003A3 (en) | 2003-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK287819B6 (sk) | Dry powder pharmaceutical composition for oral administration | |
| KR100780156B1 (ko) | 맛 차폐용 코팅 조성물 | |
| US5019563A (en) | Pharmaceutical composition | |
| US4321253A (en) | Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration | |
| US4507276A (en) | Analgesic capsule | |
| US9034382B2 (en) | Oseltamivir phosphate granule and preparation method thereof | |
| US9827197B2 (en) | Diclofenac formulations and methods of use | |
| AU630536B2 (en) | Pimobendan compositions | |
| EA023305B1 (ru) | Гранулят гамма-гидроксимасляной кислоты | |
| KR19980702370A (ko) | 염기성 물질로 안정화된 약제학적 조성물 | |
| HU206265B (en) | Process for producing pharmaceutical compositions comprising morphine | |
| SK322002A3 (en) | Taste masked pharmaceutical liquid formulations | |
| JPH0259515A (ja) | 鎮痛活性及び抗炎症活性を有し、優れた嗜好性をもち、且つ粘膜に刺激作用のない経口投与用製薬組成物 | |
| SK146297A3 (en) | Composition comprising amoxycillin and clavulanic acid | |
| CA2684586A1 (en) | High dose composition of ursodeoxycholic acid | |
| WO2001097803A1 (en) | Pharmaceutical preparations comprising racecadotril (acetorphan) | |
| BG60901B1 (bg) | Гранулат,съдържащ натриев 2-меркаптоетансулфонаткато активно вещество и метод за получаването му | |
| JPH0296526A (ja) | 粉粒状医薬製剤 | |
| KR100395864B1 (ko) | 트리메부틴을함유하는신규제약조성물및그제조방법 | |
| Kulkarni | Formulation and Evaluation of Telmisartan Fast Dissolving Tablets by Different Techniques | |
| WO2016038623A2 (en) | Taste masked stable pharmaceutical dosage form | |
| JPS5967222A (ja) | 持続性セフアトリジン製剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4A | Expiry of patent |
Expiry date: 20210622 |